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Abstract
Objective To prospectively examine coronary artery pla-
ques as predictors of myocardial ischaemia using cardiac
magnetic resonance (CMR).
Methods Fifty-two patients (46 men; age 64±10) with
suspected coronary artery disease (CAD) referred for
catheter coronary angiography (CA) underwent CMR and
computed tomography coronary angiography (CTCA). All
coronary segments were evaluated for morphological
stenosis based on CA. Any plaque according to its
composition was assessed based on CTCA.
Results Numbers of total and calcified coronary artery
plaques represented the best predictors of myocardial ischae-
mia (AUC=0.87; [95%CI: 0.77–0.97] and AUC=0.87; [95%
CI: 0.77–0.96], respectively, p=0.56) with the total plaque
number significantly higher in patients with corresponding
ischaemia than those without (p<0.01, p<0.05 adjusted for
pre-test probability and stenosis). Compared with the AUC
of coronary stenosis assessment by CA (AUC=0.90; [95%
CI: 0.80–1.00]), AUCs were equivalent using either the total
number or the number of calcified plaques alone (p=0.73
and p=0.69). Multivariate logistic regression analyses
demonstrated the total plaque number as an independent
predictor of ischaemia (odds +20%; [95%CI: 1.096–1.368]),
improving a model including clinical probability estimates of
CAD (c-statistics, 0.66 to 0.89).
Conclusion Coronary artery plaque number according to
CTCA is a significant, independent predictor of myocardial
ischaemia with similar accuracy to stenosis assessment.
Keywords Coronary artery plaque .Myocardial
ischaemia . Cardiac magnetic resonance . Computed
tomography coronary angiography . Coronary artery disease
Introduction
Computed tomography coronary angiography (CTCA) has
become a valuable alternative to conventional coronary
angiography (CA) for the reliable diagnosis or exclusion of
morphological coronary artery disease (CAD) [1–4]. Nev-
ertheless, assessment of coronary artery stenosis by both
CTCA and CA insufficiently predicts myocardial ischae-
mia, considered to be the haemodynamic consequence of a
coronary stenosis [5, 6].
Contrary to CA, CTCA, being a cross-sectional imaging
technique, does not only provide luminographic informa-
tion on the degree of coronary artery stenosis, it addition-
ally enables the detection and characterisation of coronary
plaques with good correlation with the clinical reference
standard technique, intravascular ultrasound [7–9]. The
association of coronary atherosclerotic plaque with myo-
cardial ischaemia is of considerable clinical interest
regarding effective risk stratification [10].
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The purpose of this study was to prospectively examine
coronary artery plaques as a predictor of myocardial
ischaemia as determined by cardiac magnetic resonance
(CMR).
Materials and methods
The study protocol was approved by the local institutional
review board and ethics committee. All patients gave
written informed consent before enrolment.
This was a single-centre, observational, cross-sectional
study that was conducted prospectively, enrolling 57
patients who were referred for evaluation of suspected
CAD by CA.
Exclusion criteria for CT were impaired renal function
(creatinine level >120 μmol/L, n=1), known hypersensi-
tivity to contrast medium and atrial fibrillation. Imaging
with prospective electrocardiography (ECG)-gating was not
performed in patients with heart rates >70 bpm (n=1) [11].
No medication for heart rate control was administered prior
to CT.
Exclusion criteria for CMR were contraindications to
adenosine (second, n=1, or third degree AV block, sick
sinus syndrome, symptomatic bradycardia, severe asthma
or obstructive pulmonary disease, n=1) or to magnetic
resonance imaging (implanted electronic devices, metallic
foreign bodies in the eye, severe claustrophobia (n=1), and
others according to local regulations and manufacturer’s
recommendations). The final study population consisted of
52 patients (46 men, six women; age 64±10, range 41–77).
Clinical probability assessment
We prospectively collected data about each patient’s
demographics, risk factor profile (i.e. hypertension, n=37;
hyperlipidaemia, n=36; diabetes, n=10; smoking, n=16,
family history of CAD, n=8) and type of chest pain.
Patients presented with pre-test probabilities between 3%
and 94% yielding an intermediate probability of 54.7%±
38.4% [12].
Computed tomography
Protocol
All CT studies were performed on first-generation dual-
source CT (Somatom Definition, Siemens Healthcare,
Forchheim, Germany) using prospective ECG-gating. All
patients received a single 2.5-mg dose of sublingual
isosorbide dinitrate (Isoket, Schwarz Pharma). Contrast
agent (iopromide, Ultravist 370, Bayer AG, Zurich,
Switzerland) was applied using a dual-head power injector
(Stellant, Medrad, Indianola, PA, USA) and was controlled
by bolus-tracking using a region-of-interest in the ascend-
ing aorta. Contrast media injections were followed by a
chaser bolus. Data were acquired in the cranio-caudal
direction during mid-inspiration using the parameters:
detector collimation, 2×32×0.6 mm; slice acquisition, 2×
64×0.6 mm by means of a z-flying spot; gantry rotation
time, 0.33 s. Attenuation-based tube current modulation
was used with a reference tube current-time product set at
190 mAs per rotation. The data acquisition window was set
at 70% of the R–R interval; the temporal resolution was
83 ms. CT images were reconstructed with a slice thickness
of 0.6 mm (increment 0.4 mm), using a medium smooth-
tissue convolution kernel (B26f). Additional reconstruc-
tions were performed using a sharp-tissue convolution
kernel (B46f) to compensate for blooming artefacts. All
images were transferred to an external workstation (Multi-
Modality Workplace, Siemens Healthcare) for analysis.
Image analysis
Computed tomography data analysis was performed by two
experienced radiologists who were blinded to the demo-
graphics of the patients, their clinical history and to the
results from any other tests, notably CMR and CA. All
segments with a diameter ≥1 mm at their origin were
included. Vessel segments distal to occlusions were
excluded from analysis. Coronary segments were defined
according to a scheme proposed by the American Heart
Association (AHA) [13]. The left main (segment 5) and the
intermediate artery (segment 16), if present, were consid-
ered to belong to the left anterior descending coronary
artery (LAD).
One reader rated the image quality of each coronary
segment as being diagnostic or non-diagnostic. Degree of
stenosis assessment was performed by the same reader
based on comparison of the luminal diameter of the
segment exhibiting stenosis with the mean luminal diameter
of normal-appearing coronary sections just proximal and
distal to the stenosis.
Plaque number and composition
All segments were evaluated for the presence or absence
of atherosclerotic plaques by two independent readers.
Coronary artery plaque was defined as any discernible
structure >1 mm3 that could be assigned to the coronary
artery wall [8]. Readers ascribed the beginning and end of
a plaque by visually determining discontinuity of lesions.
All plaques were assessed for the presence of any plaque
and non-calcified, mixed, or calcified plaque [8, 14]
(window setting 500 HU width, 200 HU level). Non-
calcified plaque was defined as any clearly discernible
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structure that could be assigned to the coronary artery wall
in at least two independent image planes and had a CT
density less than 130 HU but greater than the surrounding
connective tissue. Calcified atherosclerotic plaque was
defined as any structure within the coronary artery wall
with a density of 130 HU or more that could be separated
from the contrast-enhanced coronary lumen. When any
non-calcified components were identified in the presence
of calcified constituents of the same plaque, the plaque
was classified as mixed. Only plaques that did not contain
any calcium were classified as non-calcified. Plaque
number was determined by counting the plaques on an
artery basis according to plaque type. In cases of
disagreement, a consensus reading between the two read-
ers was performed.
Catheter angiography
Catheter angiography studies were evaluated by an experi-
enced reader who was blinded to the results of CMR and
CT but who was not blinded to the patients’ history and
symptoms. Vessels were quantitatively assessed (quantita-
tive coronary angiography, QCA) with the use of an
automated edge-detection system (Xcelera 1.2, Philips
Medical Systems, Best, The Netherlands). Vessel diameter
measurements were performed in at least two, preferable
orthogonal image planes and included the diameter of the
reference vessel (proximal and distal to the stenosis) and
the minimal luminal diameter. Stenosis in each segment
was classified according to the maximal luminal diameter
stenosis present in each segment [15].
Cardiac magnetic resonance
Protocol
Cardiac magnetic resonance was performed on the same
day and before CTCA. The patient was imaged on a 1.5-T
MR whole body scanner (Intera CV; Philips Medical
Systems, Best, the Netherlands) equipped with a Nova
gradient system (33 mT/m,160 [mT×m−1]/msec) using a
five-element cardiac synergy coil for signal reception.
Cardiac synchronisation was performed by ECG. All data
were acquired during breath-hold in end-inspiration. The
true short-axis of the left ventricle was determined from
long-axis scout images. Three representative short-axis
sections were obtained accordingly [10]. Adenosine stress
(Krenosin, sanofi-aventis, Switzerland) was applied at
140 μg/min per kilogram of body weight over 3.0 min
under ECG, oxygen-saturation and blood pressure moni-
toring. Gadolinium-based contrast media (Gadovist 1.0;
Bayer AG, Zurich, Switzerland; @ 0.1 mmol per kilogram
of body weight, injection rate of 5.0 ml/s, followed by a 40-
mL saline flush) was administered at 2 min 30 s after the
beginning of pharmacological stress with the acquisition of
perfusion-CMR images. Ten minutes after stress perfusion
imaging, a second bolus of contrast media was injected and
rest perfusion images were obtained with the same
orientation and position as in stress imaging. Previous
knowledge driven k-t sensitivity encoding perfusion-CMR
imaging was used in combination with a saturation
recovery gradient-echo pulse sequence (repetition time/
echo time, 3.1/1.1 ms; flip angle, 20°; saturation pre-pulse
delay, 110 ms; partial Fourier sampling; acquisition
window, 120 ms; section thickness, 10 mm; k-t factor of
five with 11 k-t interleaved training profiles; effective
acceleration, 3.7; three sections acquired sequentially
during a single R–R interval) [4]. Perfusion-CMR was
acquired with an in-plane resolution of 2.0×2.0 mm
(reconstructed in-plane resolution of 1.25×1.25 mm). Ten
minutes after rest perfusion, late gadolinium enhancement
(LGE) images were acquired in continuous short-axis view
using an inversion-recovery gradient-recalled echo MRI
sequence with the following parameters: field of view, 350–
400 mm; repetition time/echo time, 7.4/4.3 ms; inversion
time, 200–350 ms; flip angle, 20°; matrix, 240×240; slice
thickness, 10 mm. Inversion time was chosen to null the
signal from normal myocardium.
Image analysis
Perfusion stress and rest images as well as LGE images
were analysed by one experienced reader, who was blinded
to the patient’s demographics and the results of CTCA and
CA. Perfusion deficits and LGE were detected by subjec-
tive visual analysis [5]. Myocardial ischaemia was defined
as (a) territories without LGE that showed a perfusion
deficit during stress perfusion, but not at rest (stress-
inducible deficit), for three or more consecutive image
frames, and (b) territories with non-transmural LGE
demonstrating additional stress-inducible perfusion deficits
extending larger than LGE [11]. Segments were allocated
according to standard definitions [10].
Statistical analysis
Quantitative data are expressed as means ± SD, categorical
data are given as frequencies (percentages). To prove the
association of stenosis >50% by CTCA and CA with
myocardial ischaemia, two-by-two tables were fitted and
Fisher’s exact test was used to compare proportions.
Inter-reader reliability regarding the assessment of total
plaque number and composition of plaque was assessed
with κ statistics.
To assess the association of coronary artery plaques with
myocardial ischaemia, total numbers of plaques in patients
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with underlying ischaemia were compared with those in
patients without ischaemia using the Mann–Whitney U test
and ANOVA with parameters of pre-test probability and
coronary stenosis as co-variates. Univariate associations of
total number of plaques, numbers of plaques according to
their composition, and coronary stenosis by CA with
myocardial ischaemia were additionally carried out through
the use of receiver operating characteristic (ROC) analyses.
We performed multivariate logistic regression analyses
with stepwise forward entry to determine whether the total
number of coronary plaques added incremental value to the
outcome variable myocardial ischaemia. The model initially
included clinical probability estimates. In a second step, we
added the total number of plaques as a continuous variable
to the model. In a third step, we added coronary stenosis
according to CA. Because co-linearity between CTCA and
Fig. 1 Conventional coronary
angiography rules out signifi-
cant stenosis in the right coro-
nary artery (RCA, a), the left
anterior descending artery (LAD,
b), and the circumflex artery in
this 71-year-old male patient.
Accordingly, CT coronary angi-
ography does not show evidence
of stenosis >50% but demon-
strates numerous calcified coro-
nary plaques in the RCA (c) and
the LAD (d). Perfusion cardiac
magnetic resonance indicates
stress-induced ischaemia (e) in
mid-ventricular septal segments
(arrows) in the presence of
normal rest perfusion (f)
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CA regarding coronary stenosis was demonstrated by linear
regression analysis (r=0.92, p<0.001), only measurements
derived from CA were added to the model.
The goodness-of-fit of the model was evaluated using
the Hosmer-Lemeshow test and c statistics.
Statistical analysis was performed using commercially
available software (SPSS, release 18.0.0; SPSS, Chicago,
IL, USA). A p value of <0.05 was considered significant.
Results
All CTCA and CMR examinations were performed within
1 day. The mean time interval between CTCA/CMR and
CA was 17±8 days (range, 1–38 days). After adenosine
injection, no adverse effects leading to discontinuation of
CMR were observed.
Cardiac MR image analysis revealed myocardial ischae-
mia in 29/52 (56%) patients.
Inter-reader reliability for the assessment of total plaque
number and composition of plaque was κ=0.71 and
κ=0.63, respectively.
A total of 655 plaques (LAD, 294; RCA, 240; CX, 121)
were found in 45/52 (87%) patients. Of those, 452/655
(69.0%) were calcified (LAD, 225; RCA, 145; CX, 82), 91/
655 (13.9%) were non-calcified (LAD, 42; RCA, 29; CX,
20), and 112/655 (17.1%) were of mixed composition
(LAD, 27; RCA, 66; CX, 19). Arteries with corresponding
ischemia had significantly more calcified and mixed
plaques than arteries without corresponding ischemia
(p<0.0001).
Patients with corresponding ischaemia exhibited a
significantly higher number of total plaques than those
without corresponding ischaemia (p<0.01) which remained
significantly different (p<0.05) after adjustments for pre-
test probability and stenosis (Fig. 1). Areas under the curves
for the prediction of ischaemia were greatest and similar
(p=0.56) when considering the total number of plaques
(AUC=0.87; [95% CI: 0.77, 0.97]); and the number of
calcified plaques (AUC=0.87; [95%CI: 0.77, 0.96]). AUCs
for the numbers of non-calcified and mixed plaques were
AUC=0.60 [95%CI: 0.44, 0.75] and AUC=0.71 [95%CI:
0.56, 0.85], respectively (Fig. 2).
Compared with the AUC regarding coronary stenosis
assessment by CA (AUC=0.90 [95%CI:0.80, 1.00]), AUCs
were equivalent regarding either the total number or the
number of calcified plaques alone (p=0.73 and p=0.69,
respectively).
Table 1 summarises the association between ischaemia
and the different variables in the various model steps. The
Hosmer and Lemeshow test showed a good model fit (first
step significance p=0.31, second; p=0.57; third, p=0.76).
Fig. 2 Receiver operating characteristic curves for plaque numbers
according to plaque composition as determined by CTCA adjusted
versus myocardial ischaemia at CMR
Table 1 Logistic regression analyses for the prediction of ischaemia
Coefficient SD β estimate 95%CI P C statistics
(a) Model for the probability of ischaemia according to Diamond and Forrester
Risk 0.020 0.008 1.020 1.005–1.036 <0.05 0.66
(b) Model for the probability of ischaemia according to Diamond and Forrester as well as total number of plaques
Risk 0.022 0.011 1.023 1.001–1.044 <0.05
Plaquea 0.203 0.057 1.225 1.096–1.368 <0.001 0.89
(c) Model for the probability of ischaemia according to Diamond and Forrester, total number of plaques, and coronary stenosis
Risk 0.007 0.014 1.007 0.980–1.034 0.63
Plaquea 0.143 0.074 1.153 0.998–1.332 0.05
Stenosisb 4.108 1.290 60.854 4.859–762.159 <0.01 0.93
Note similarity of C values regarding models (b) and (c). Plaque numbera and coronary stenosis >50%b derived from CTCA and CA, respectively.
CAD coronary artery disease, SD standard deviation; CI confidence interval
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Multivariate logistic regression demonstrated that the
total number of plaques improved the initial model
including clinical probability estimates of CAD alone (c
statistic, 0.66 to 0.89). The average increase in odds of
having ischaemia by each additional plaque was 20% (95%
CI: 1.096–1.368) when only traditional risk factor assess-
ment is considered.
Adding the degree of stenosis improved the c value of
the model by 0.04 (c statistics, 0.89 to 0.93, see Table 1),
and was associated with an increased p value for probability
estimates and plaque numbers.
Discussion
This study analysed the relationship between coronary
artery plaques and plaque composition according to CTCA
with myocardial ischaemia as determined by CMR, in
comparison with the prediction of ischaemia based on
luminographic analysis of coronary artery stenosis. Our
results indicate the total plaque number to be a significant
predictor of myocardial ischaemia with an incremental
value over traditional risk factor assessment which is
independent of coronary stenosis assessment.
We demonstrated that the plaque numbers were higher in
patients with myocardial territories showing ischaemia re-
gardless of coronary stenosis. In our analysis, the accuracy for
predicting myocardial ischaemia by the total and calcified
coronary artery plaque numbers was similar to that by using
coronary stenosis alone. A comparable relationship has
recently been described by Schenker et al. [10], who
demonstrated that the coronary artery calcium score (CAC)
correlates well with myocardial ischaemia.
Although coronary artery calcium (CAC) scoring is
recommended to measure the extent of calcified coronary
plaques and for risk stratification [16], it does not allow for
the identification of non-calcified components of athero-
sclerotic plaques. This is similarly reflected by the results of
Schenker and colleagues [10]. Sixteen percent of their
patients with a CAC of zero still showed myocardial
ischaemia. In our study, we evaluated all plaques according
to their different compositions by the use of data from
contrast-enhanced CTCA rather than CAC.
In addition, arteries with corresponding ischemia had
more plaques than arteries without ischemia. Thus, we may
believe that plaque number might be helpful in ascribing
functional defects to culprit arteries.
The fact that the numbers of non-calcified and/or mixed
plaques were weaker univariate predictors than total and
calcified plaque numbers can be attributed to the inclusion
of patients [7]. It can be well speculated that non-calcified
and/or mixed plaques would be better predictors in patients
presenting with acute coronary syndromes.
We were able to demonstrate that coronary artery plaque
burden is a significant, independent predictor of myocardial
ischaemia, improving a model based on the clinical
probability estimates for CAD alone [12] which holds true
in patients with low to high pre-test risks. Herein, the odds
of myocardial ischaemia increased by 20% for each
additional plaque. Conversely, the addition of coronary
stenosis by CA significantly improved neither the c
statistics nor the goodness-of-fit of the model.
Overall, our study indicates that an elevated plaque
number may be indicative of ischaemia in symptomatic
patients regardless of degree of stenosis, potentially
rendering subsequent stress-perfusion CMR appropriate
[17].
There were a few study limitations. First, we did not
determine the volume or configuration of the plaque and
plaque assessment was done on a visual basis as described
previously [8, 14]. Second, statistical models only consider
coronary artery stenosis >50% as measured in one imaging
plane. Third, we did not investigate patients with acute
coronary syndromes which might have indicated the role of
non-calcified and mixed plaques with regard to myocardial
ischaemia. Fourth, our results apply to a selected patient
cohort referred for CA. Furthermore, most of the patients
in our cohort were male. Although we found a good
accuracy for the detection of myocardial ischaemia on
the basis of plaque numbers and composition in our
cohort, this relationship may be different in other patient
cohorts consisting, among others, of a higher percentage
of women.
Conclusion
Coronary artery plaque number according to CTCA is a
significant, independent predictor of myocardial ischaemia
with similar accuracy to that of using coronary stenosis
assessment.
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